Lumos Pharma Announces Abstracts Accepted for Presentation at ENDO 2024
AUSTIN, Texas, May 20, 2024 -- Lumos Pharma, Inc. , a clinical stage biopharmaceutical company focused on therapeutics for rare diseases, announced today that new analyses of data from its Phase 2...
Source: marketscreener.com